Role of training dose in drug discrimination
- 1 September 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Behavioural Pharmacology
- Vol. 22 (5 and 6) , 415-429
Abstract
Drug discrimination has been an important technique in behavioural pharmacology for at least 40 years. The characteristics of drug-produced discriminative stimuli are influenced by behavioural and pharmacological variables, including the doses used to establish discriminations. This review covers studies on the effects of varying the training dose of a drug in a search for general principles that are applicable across different drug classes and methodological approaches. With respect to quantitative changes, relationships between training dose and the rate of acquisition or magnitude of stimulus control were found for most drug classes. Acquisition accelerated with dose up to a point beyond which drug-induced impairments of performance had a deleterious impact. Sensitivity to the training drug as measured by ED50 values typically increased when the training dose was reduced. Qualitative changes were more complex and appeared to fall into three categories: (a) changes in profiles of generalization between partial and full agonists; (b) reduced specificity of some discriminations at small training doses; and (c) changes in the relative salience of actions mediated through different neurotransmitter systems or from central and peripheral sites. Three-lever discrimination procedures incorporating ‘drug versus drug’ or ‘dose versus dose’ contingencies enabled detection of more subtle differences than the simple ‘drug versus no drug’ approach when applied to the opioid, hallucinogen and barbiturate classes of drugs. These conclusions have implications for the interpretation of data from studies that use either within-subject or between-subject designs for studying the discriminative stimulus effects of drugs.Keywords
This publication has 152 references indexed in Scilit:
- Analysis of the 5‐HT2 Receptor Ligands Dimethoxy‐4‐indophenyl‐2‐aminopropane and Ketanserin in Ethanol DiscriminationsAlcohol, Clinical and Experimental Research, 1998
- Discriminative stimulus effects of cocaine in female versus male ratsDrug and Alcohol Dependence, 1996
- Blockade of the discriminative stimulus effects of γ-hydroxybutyric acid (GHB) by the GHB receptor antagonist NCS-382Physiology & Behavior, 1995
- Discriminative stimulus effect of flesinoxan: Effects of 5-HT1A antagonists and PCPAPharmacology Biochemistry and Behavior, 1994
- Pharmacological specificity of the phencyclidine discriminative stimulus in ratsPharmacology Biochemistry and Behavior, 1991
- Further studies on the dose-dependent stimulus properties of 5-methoxy-N,N-dimethyltryptaminePharmacology Biochemistry and Behavior, 1986
- Effects of the training dose on generalization of morphine stimulus to clonidinePharmacology Biochemistry and Behavior, 1984
- Nisoxetine and amphetamine share discriminative stimulus properties in micePharmacology Biochemistry and Behavior, 1983
- Behavioral and biochemical evidence for serotonergic actions of tetrahydro-β-carbolinesLife Sciences, 1982
- Lysergic Acid Diethylamide (LSD) and Lisuride: Differentiation of Their Neuropharmacological ActionsScience, 1982